1995
DOI: 10.1038/bjc.1995.377
|View full text |Cite
|
Sign up to set email alerts
|

Prostate-specific membrane antigen: evidence for the existence of a second related human gene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
56
0
1

Year Published

1997
1997
2019
2019

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 78 publications
(57 citation statements)
references
References 16 publications
0
56
0
1
Order By: Relevance
“…12). Preliminary data indicate that I100 is localized to chromosome 11 2 and may potentially explain the second weaker fluorescent in situ hybridization band that has been previously reported for the PSM gene (34,35).…”
Section: Discussionmentioning
confidence: 99%
“…12). Preliminary data indicate that I100 is localized to chromosome 11 2 and may potentially explain the second weaker fluorescent in situ hybridization band that has been previously reported for the PSM gene (34,35).…”
Section: Discussionmentioning
confidence: 99%
“…10). Whether these three species arise by expression from different genes (23,24) or from differential splicing (25) or consist of heteronuclear RNAs remains to be determined. In previous Northern blot experiments, three additional smaller bands of hybridization had been detected in rat brain and kidney with estimated sizes of 2,100, 750, and 500 nucleotides (10).…”
Section: Resultsmentioning
confidence: 99%
“…Chromosome 11 contains a number of genetic disease loci in these regions, including vitreoretinopathy (11q13-q23), xeroderma pigmentosa (11q12-q13), atopy (11q12-q13), and perhaps more interestingly, a tumor suppression locus (11p11.2-p11.13) involved in rat prostate carcinoma. Introduction of this portion of the chromosome into highly metastatic rat prostatic cells was able to suppress cancer metastases without suppression of the in vivo growth rate or tumorigenicity of the cells (32). Since it has been shown that NAALADase I expression increases with decreasing androgen levels, it is possible that current prostate cancer treatments involving androgen level reduction (e.g.…”
Section: Discussionmentioning
confidence: 99%